PMGC HOLDINGS INC. Additional Paid in Capital, Preferred Stock
PMGC HOLDINGS INC. (ELAB) had Additional Paid in Capital, Preferred Stock of $130.86 million as of 2022-07-15, per its 10-Q filed 2023-12-11.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:AdditionalPaidInCapitalPreferredStock · last filed 2023-12-11
- 2022-07-15: Additional Paid in Capital, Preferred Stock $130.86M.
| Period end | Additional Paid in Capital, Preferred Stock |
|---|---|
| 2022-07-15 | $130.86M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |